STOCKWATCH
·
Pharmaceuticals
New Launch1 Dec 2025, 12:22 pm

Granules India Strengthens R&D Leadership with Two New Centres of Excellence at IIT Hyderabad’s Technology Research Park

AI Summary

Granules India Limited has inaugurated two Centres of Excellence at the Technology Research Park of IIT Hyderabad: the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering. The Ascelis Center will drive the development of cosmetic, therapeutic, and pharmaceutical peptides, while the Granules Center will advance polymorph research, material science, and novel drug delivery systems. These Centres significantly strengthen Granules' capabilities in peptides and advanced material sciences, enhancing their CDMO ambitions and global competitiveness.

Key Highlights

  • Granules India Limited has launched two Centres of Excellence at IIT Hyderabad’s Technology Research Park.
  • The Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides.
  • The Granules Center of Excellence for Particle Engineering will advance polymorph research, material science, and novel drug delivery systems.
  • These Centres significantly strengthen Granules' capabilities in peptides and advanced material sciences.
  • This move enhances Granules' CDMO ambitions and global competitiveness.
GRANULES
Pharmaceuticals
GRANULES INDIA LTD.-$

Price Impact